Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:COCHNASDAQ:NMTCNASDAQ:NXLNASDAQ:SINT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCOCHEnvoy Medical$1.60+0.9%$1.45$1.21▼$3.99$34.12M2.3380,908 shs22,854 shsNMTCNeuroOne Medical Technologies$0.64+1.3%$0.63$0.40▼$1.39$31.80M0.65182,353 shs83,784 shsNXLNexalin Technology$1.19$1.59$0.53▼$4.49$20.44M4.671.24 million shs95,078 shsSINTSintx Technologies$2.79+3.3%$2.52$1.71▼$8.60$6.77M0.82945,248 shs52,027 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCOCHEnvoy Medical+0.95%-3.90%+14.29%+16.79%-31.33%NMTCNeuroOne Medical Technologies+0.57%+3.62%+3.94%-42.75%-35.20%NXLNexalin Technology0.00%-1.65%-34.62%-56.09%+78.95%SINTSintx Technologies+3.33%-0.71%+16.74%-15.71%-64.32%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCOCHEnvoy Medical3.3348 of 5 stars3.55.00.00.03.03.30.0NMTCNeuroOne Medical Technologies2.5761 of 5 stars3.55.00.00.01.81.70.0NXLNexalin Technology3.5347 of 5 stars3.55.00.00.03.93.30.0SINTSintx Technologies2.9669 of 5 stars3.55.00.00.02.01.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCOCHEnvoy Medical 3.00Buy$9.25478.13% UpsideNMTCNeuroOne Medical Technologies 3.00Buy$1.45127.17% UpsideNXLNexalin Technology 3.00Buy$5.00320.17% UpsideSINTSintx Technologies 3.00Buy$30.00975.27% UpsideCurrent Analyst Ratings BreakdownLatest SINT, COCH, NMTC, and NXL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2025COCHEnvoy MedicalAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.25 ➝ $9.505/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.454/21/2025COCHEnvoy MedicalAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$9.00 ➝ $9.254/21/2025SINTSintx TechnologiesAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$70.00 ➝ $30.003/24/2025NXLNexalin TechnologyMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$5.00(Data available from 5/30/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCOCHEnvoy Medical$212K160.96N/AN/A($0.09) per share-17.78NMTCNeuroOne Medical Technologies$5.76M5.52N/AN/A$0.10 per share6.38NXLNexalin Technology$131.07K155.97N/AN/A$0.43 per share2.77SINTSintx Technologies$1.23M5.70N/AN/A$329.74 per share0.01Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCOCHEnvoy Medical-$29.91M-$1.38N/AN/AN/A-7,607.55%N/A-262.28%8/11/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.22N/A∞N/A-82.17%-270.70%-129.70%8/13/2025 (Estimated)NXLNexalin Technology-$4.65M-$0.83N/A∞N/A-3,407.98%-187.59%-167.21%N/ASINTSintx Technologies-$8.26M-$50.56N/A∞N/A-358.79%-140.68%-78.29%8/4/2025 (Estimated)Latest SINT, COCH, NMTC, and NXL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025SINTSintx Technologies-$0.71-$1.29-$0.58-$1.29$0.73 million$0.37 million5/13/2025Q2 2025NMTCNeuroOne Medical Technologies-$0.09-$0.07+$0.02-$0.07$1.27 billion$1.39 billion5/13/2025Q1 2025NXLNexalin Technology-$0.10-$0.15-$0.05-$0.15$0.04 million$0.04 million3/28/2025Q4 2024COCHEnvoy Medical-$0.33-$0.45-$0.12-$0.45$0.07 million$0.04 million3/14/2025Q4 2024NXLNexalin TechnologyN/A-$0.28N/A-$0.28N/A$0.03 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCOCHEnvoy MedicalN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/ANXLNexalin TechnologyN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCOCHEnvoy MedicalN/A0.790.61NMTCNeuroOne Medical TechnologiesN/A3.642.41NXLNexalin TechnologyN/A16.4215.89SINTSintx TechnologiesN/A3.042.82Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCOCHEnvoy Medical8.59%NMTCNeuroOne Medical Technologies16.07%NXLNexalin Technology0.65%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipCOCHEnvoy Medical60.50%NMTCNeuroOne Medical Technologies8.90%NXLNexalin Technology24.00%SINTSintx Technologies0.01%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCOCHEnvoy Medical3421.33 million8.00 millionNot OptionableNMTCNeuroOne Medical Technologies2049.82 million28.12 millionOptionableNXLNexalin Technology317.18 million10.11 millionNot OptionableSINTSintx Technologies402.51 million1.34 millionNot OptionableSINT, COCH, NMTC, and NXL HeadlinesRecent News About These CompaniesSintx Technologies Draws Heavy Retail Buzz On New Patent Push, SubsidiaryMay 23, 2025 | msn.comSINTX Technologies Announces Patent Issuance and Formation of Subsidiary to Advance Antimicrobial Applications in the Agribiotech MarketMay 22, 2025 | globenewswire.comSiNtx Technologies Inc.May 19, 2025 | marketwatch.comSiNtx Technologies Inc.May 19, 2025 | marketwatch.comSINTX Technologies, Inc.: SINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device CommercializationMay 16, 2025 | finanznachrichten.deMark Lewis Anderson Purchases 5,000 Shares of Sintx Technologies, Inc. (NASDAQ:SINT) StockMay 15, 2025 | insidertrades.comSINTX Technologies Provides Business Update Highlighting Strategic Focus to Medical Device CommercializationMay 15, 2025 | globenewswire.comSintx Technologies, Inc. (NASDAQ:SINT) Insider Gregg R. Honigblum Buys 10,000 SharesMay 1, 2025 | insidertrades.comSintx Technologies Appoints Five New Board DirectorsApril 8, 2025 | tipranks.comSintx Technologies announces changes to board, Chairman Bal to retireApril 5, 2025 | markets.businessinsider.comSINTX Technologies Announces Strategic Changes to Board of DirectorsApril 3, 2025 | markets.businessinsider.comSINTX: Peer-reviewed Study Shows Biomechanical Advantages Of Silicon Nitride In ACDF ProceduresMarch 21, 2025 | nasdaq.comMaxim Group Reaffirms Their Hold Rating on Sintx Technologies (SINT)March 21, 2025 | markets.businessinsider.comSintx Technologies announces publication of study on silicon nitride in ACDFMarch 20, 2025 | markets.businessinsider.comSintx Technologies files to sell 3.01M shares of common stock for holdersMarch 20, 2025 | markets.businessinsider.comSINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine FusionMarch 19, 2025 | markets.businessinsider.comSintx Technologies Announces Board Chairman TransitionMarch 17, 2025 | markets.businessinsider.com3SINT : Why SINTX Technologies Stock Is Down 21%February 26, 2025 | benzinga.comSintx Technologies prices 1.45M shares at $3.45 in private placementFebruary 26, 2025 | markets.businessinsider.comSINTX Technologies Announces $5 Million Private Placement Priced At-the-Market under Nasdaq RulesFebruary 26, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSINT, COCH, NMTC, and NXL Company DescriptionsEnvoy Medical NASDAQ:COCH$1.60 +0.02 (+1.26%) As of 05/29/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.NeuroOne Medical Technologies NASDAQ:NMTC$0.64 +0.01 (+1.32%) Closing price 05/29/2025 03:49 PM EasternExtended Trading$0.63 0.00 (-0.67%) As of 05/29/2025 08:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Nexalin Technology NASDAQ:NXL$1.19 0.00 (0.00%) Closing price 05/29/2025 03:59 PM EasternExtended Trading$1.16 -0.03 (-2.94%) As of 05/29/2025 06:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.Sintx Technologies NASDAQ:SINT$2.79 +0.09 (+3.33%) Closing price 05/29/2025 04:00 PM EasternExtended Trading$2.80 +0.01 (+0.36%) As of 05/29/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook Salesforce’s Stock Price Presents an Opportunity to Buy NVIDIA Will Set a New High Soon, Then Keep Rallying, Here’s Why Goodyear Stock Surges 28% in 2025: Is More Growth Ahead? Intel's Loss Is Broadcom's Gain as AVGO Dominates Networking Target's Big Bet: Is It a Cheap Stock or a Value Trap? Dividend Investors Looking for an Edge? 3 Stocks Insiders Bought Toyota Supercharges Joby: $250M Capital Infusion Ignites Stock Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
